The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan
Study Details
Study Description
Brief Summary
This study aimed to assess the impact of the clinical pharmacist on enhancing type 2 diabetic patients outcomes in a primary health care center.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
About 103 patients with type 2 diabetes were randomized to control or intervention group, the control group received a standard care, while the intervention group received the collaborative care between the clinical pharmacist and physicians. Fasting blood glucose, HbA1c, Lipid profile, and blood pressure measured for both groups at baseline and after three months of follow-up. Treatment related problems (TRPs), quality of life, adherence, and patients knowledge about their medications were assessed. Cost avoidance and clinical significance of implemented clinical pharmacist interventions were assessed too.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: the intervention group this group received the collaborative care between the clinical pharmacist and physicians in a medical center |
Other: Collaborative approach of clinical pharmacist with physicians in a medical center
For those who allocated to the intervention group, the clinical pharmacist interviewed them at each monthly visit about 30 minutes before seeing physicians, the clinical pharmacist identified treatment related problems, provided medication counseling, answered questions asked by patients or physicians, encouraged compliance, offered instructions on self-monitoring of blood pressure and glucose levels, distributed educational materials about diabetes and emphasis was made on optimizing adherence to pharmacological and non- pharmacological therapy. the pharmacist interventions on treatment related problems (TRPs) and proposed patient care plans were discussed with treatng physicians who decided to accept or reject them.
|
No Intervention: the control group this group received the standard care of physicians in a medical center without clinical pharmacist interventions |
Outcome Measures
Primary Outcome Measures
- HbA1c [3 months]
Secondary Outcome Measures
- Lipid profile [3 months]
LDL , HDL , TGS
- Fasting blood glucose [each month for 3 months]
- blood pressure [3 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
- type 2 diabetic patients who aged 18 years or more with a HbA1c reading 6.5 % or more at the time of diagnosis
Exclusion Criteria:
-
pregnant patients
-
breastfeeding patients
-
patients with urgent or emergent cases
-
patients with cognitive impairment
-
if the patient is unable to provide informed written consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Abu-Nsair medical center | Amman | Jordan |
Sponsors and Collaborators
- University of Jordan
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Clinical pharmacist